全文获取类型
收费全文 | 2605篇 |
免费 | 220篇 |
国内免费 | 3篇 |
专业分类
2828篇 |
出版年
2021年 | 30篇 |
2019年 | 24篇 |
2017年 | 27篇 |
2016年 | 41篇 |
2015年 | 65篇 |
2014年 | 77篇 |
2013年 | 115篇 |
2012年 | 142篇 |
2011年 | 154篇 |
2010年 | 79篇 |
2009年 | 72篇 |
2008年 | 103篇 |
2007年 | 138篇 |
2006年 | 101篇 |
2005年 | 108篇 |
2004年 | 132篇 |
2003年 | 103篇 |
2002年 | 103篇 |
2001年 | 43篇 |
2000年 | 29篇 |
1999年 | 51篇 |
1998年 | 41篇 |
1997年 | 31篇 |
1996年 | 27篇 |
1995年 | 24篇 |
1994年 | 24篇 |
1993年 | 28篇 |
1992年 | 35篇 |
1991年 | 29篇 |
1990年 | 26篇 |
1989年 | 26篇 |
1988年 | 25篇 |
1987年 | 22篇 |
1985年 | 25篇 |
1984年 | 29篇 |
1982年 | 37篇 |
1981年 | 31篇 |
1980年 | 31篇 |
1979年 | 21篇 |
1978年 | 31篇 |
1977年 | 24篇 |
1976年 | 32篇 |
1975年 | 17篇 |
1974年 | 32篇 |
1973年 | 25篇 |
1972年 | 18篇 |
1969年 | 16篇 |
1964年 | 16篇 |
1961年 | 17篇 |
1957年 | 17篇 |
排序方式: 共有2828条查询结果,搜索用时 8 毫秒
891.
The polysomes isolated from the different developmental stages of Artemia salina have been translated in a homologous S-30 extract or pH 5 enzyme fraction as well as in a heterologous (wheat germ) pH 5 enzyme fraction. The specific template activity of the polysomes increases linearly up to a stage which is equivalent to about two-thirds of the whole preemergence period and thereafter remains rather constant until the nauplius stage. The specific template activity of the polysomes appears to be dependent on a source of in vitro systems, but not to be dependent on the size of the polysomes used. Moreover, the efficiency of polypeptide chain release from the polysomes in vitro also seems dependent on the developmental stages of the embryos, but in this case it is not influenced by the in vitro system employed. Analysis of the proteins synthesized in vitro by the polyacrylamide gel electrophoresis has revealed that the species and their relative amounts of the proteins are rather specific for each developmental stage analyzed.Heme-containing proteins from the nauplii have been partially purified and analyzed. This heme-protein complex contains two distinct polypeptide chains, MW > 100,000 and MW = 50,000–60,000 daltons, respectively, as the major species as judged by SDS-polyacrylamide gel electrophoresis. During preemergence development, no heme-protein complexes have been detected, but after hatching of the embryos, they have been detected. 相似文献
892.
893.
THE FINE STRUCTURE OF MEIOTIC CHROMOSOME PAIRING IN THE TRIPLOID, LILIUM TIGRINUM 总被引:1,自引:0,他引:1 下载免费PDF全文
Peter B. Moens 《The Journal of cell biology》1969,40(1):273-279
894.
Summary Rabbit articular chondrocytes immobilized in alginate beads maintained normal morphology and metabolic activity (glucose consumption) for more than two weeks whether calcium, barium, or strontium were used for the gel forming. Only Ca- and Ba-alginate immobilized chondrocytes produced proteoglycans in the external medium. Only Ca-alginate beads produced proteoglycans at a constant rate. 相似文献
895.
896.
Lesley Tilleman Stefania Abbruzzetti Chiara Ciaccio Giampiero De Sanctis Marco Nardini Alessandra Pesce Filip Desmet Luc Moens Sabine Van Doorslaer Stefano Bruno Martino Bolognesi Paolo Ascenzi Massimo Coletta Cristiano Viappiani Sylvia Dewilde 《PloS one》2015,10(6)
Studies of CO ligand binding revealed that two protein states with different ligand affinities exist in the protoglobin from Methanosarcina acetivorans (in MaPgb*, residue Cys(E20)101 was mutated to Ser). The switch between the two states occurs upon the ligation of MaPgb*. In this work, site-directed mutagenesis was used to explore the role of selected amino acids in ligand sensing and stabilization and in affecting the equilibrium between the “more reactive” and “less reactive” conformational states of MaPgb*. A combination of experimental data obtained from electronic and resonance Raman absorption spectra, CO ligand-binding kinetics, and X-ray crystallography was employed. Three amino acids were assigned a critical role: Trp(60)B9, Tyr(61)B10, and Phe(93)E11. Trp(60)B9 and Tyr(61)B10 are involved in ligand stabilization in the distal heme pocket; the strength of their interaction was reflected by the spectra of the CO-ligated MaPgb* and by the CO dissociation rate constants. In contrast, Phe(93)E11 is a key player in sensing the heme-bound ligand and promotes the rotation of the Trp(60)B9 side chain, thus favoring ligand stabilization. Although the structural bases of the fast CO binding rate constant of MaPgb* are still unclear, Trp(60)B9, Tyr(61)B10, and Phe(93)E11 play a role in regulating heme/ligand affinity. 相似文献
897.
Mona Cai Michael D. Kappelman Cynthia J. Girman Nina Jain Til Stürmer Maurice Alan Brookhart 《PloS one》2015,10(10)
Objective
To evaluate trends and identify predictors of treatment initiation of oral anti-diabetic drugs (OAD) in youth.Patients and Methods
We identified a select population of children, ages 8–18 years, with at least 13 months of continuous health plan coverage within the years 2001–2012 in a large US commercial insurance claims database. New use of an OAD was defined as the first claim for an outpatient dispensing following a 12-month wash out period. Treatment incidence was estimated monthly over the study period, and stratified by age, gender, geographic region, and provider specialty.Results
The median size of the source population during the study period was 2.2 million children. A total of 13,824 initiators (mean monthly incidence of 4.6 (95% CI = 3.6, 5.5) per 100,000 youths) were identified. Initiators were more likely to be females, age 15–18, from the southern region, and have visited a family practitioner (versus a general pediatrician) prior to initiation. Time trends demonstrate a 43% increase in initiation from 2002–2012, with a gradual decrease starting from early 2008.Conclusion
Incidence of filled OAD medications in youth increased over time, especially for patients treated by family practitioners. Additional research is needed into factors influencing prescribing by family practitioners and pediatricians. 相似文献898.
The extent of glycation and conformational changes of horse myoglobin (Mb) upon glycation with N-acetyl-glucosamine (GlcNAc), glucose (Glc) and glucosamine (GlcN) were investigated. Among tested sugars, the rate of glycation with GlcN was the most rapid as shown by MALDI and ESI mass spectrometries. Protein oxidation, as evaluated by the amount of carbonyl groups present on Mb, was found to increase exponentially in Mb-Glc conjugates over time, whereas in Mb-GlcN mixtures the carbonyl groups decreased significantly after maximum at 3 days of the reaction. The reaction between GlcN and Mb resulted in a significantly higher amount of α-dicarbonyl compounds, mostly glucosone and 3-deoxyglucosone, ranging from and 27 to 332 mg/L and from 14 to 304 mg/L, respectively. Already at 0.5 days, tertiary structural changes of Mb-GlcN conjugate were observed by altered tryptophan fluorescence. A reduction of metmyoglobin to deoxy-and oxymyoglobin forms was observed on the first day of reaction, coinciding with the greatest amount of glucosone produced. In contrast to native α-helical myoglobin, 41% of the glycated protein sequence was transformed into a β-sheet conformation, as determined by circular dichroism spectropolarimetry. Transmission electron microscopy demonstrated that Mb glycation with GlcN causes the formation of amorphous or fibrous aggregates, started already at 3 reaction days. These aggregates bind to an amyloid-specific dye thioflavin T. With the aid of α-dicarbonyl compounds and advanced products of reaction, this study suggests that the Mb glycation with GlcN induces the unfolding of an initially globular protein structure into amyloid fibrils comprised of a β-sheet structure. 相似文献
899.
Sofie HM Manders Wietske Kievit Eddy Adang Herman L Brus Hein J Bernelot Moens Andre Hartkamp Lidy Hendriks Elisabeth Brouwer Henk Visser Harald E Vonkeman Jos Hendrikx Tim L Jansen Rene Westhovens Mart AFJ van de Laar Piet LCM van Riel 《Arthritis research & therapy》2015,17(1)
IntroductionFor patients with rheumatoid arthritis (RA) whose treatment with a tumour necrosis factor inhibitor (TNFi) is failing, several biological treatment options are available. Often, another TNFi or a biological with another mode of action is prescribed. The objective of this study was to compare the effectiveness and cost-effectiveness of three biologic treatments with different modes of action in patients with RA whose TNFi therapy is failing.MethodsWe conducted a pragmatic, 1-year randomised trial in a multicentre setting. Patients with active RA despite previous TNFi treatment were randomised to receive abatacept, rituximab or a different TNFi. The primary outcome (Disease Activity Score in 28 joints) and the secondary outcomes (Health Assessment Questionnaire Disability Index and 36-item Short Form Health Survey scores) were analysed using linear mixed models. Cost-effectiveness was analysed on the basis of incremental net monetary benefit, which was based on quality-adjusted life-years (calculated using EQ-5D scores), and all medication expenditures consumed in 1 year. All analyses were also corrected for possible confounders.ResultsOf 144 randomised patients, 5 were excluded and 139 started taking abatacept (43 patients), rituximab (46 patients) or a different TNFi (50 patients). There were no significant differences between the three groups with respect to multiple measures of RA outcomes. However, our analysis revealed that rituximab therapy is significantly more cost-effective than both abatacept and TNFi over a willingness-to-pay range of 0 to 80,000 euros.ConclusionsAll three treatment options were similarly effective; however, when costs were factored into the treatment decision, rituximab was the best option available to patients whose first TNFi treatment failed. However, generalization of these costs to other countries should be undertaken carefully.
Trial registration
Netherlands Trial Register number NTR1605. Registered 24 December 2008.Electronic supplementary material
The online version of this article (doi:10.1186/s13075-015-0630-5) contains supplementary material, which is available to authorized users. 相似文献900.